Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Stick2PrEP Cisgender Women and Trans Individuals

Columbia University · with Merck Sharp & Dohme LLC · NCT05165745

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18+ · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Not applicable
Target enrollment
175
US sites recruiting
1
Study start
October 25, 2021
Record last updated
September 2, 2025

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

Taking a daily anti-HIV pill can protect people from HIV infection. This is called preexposure prophylaxis [PrEP]. Many cisgender women and trans individuals do not know this medication is available; others struggle to take the pill every day. It is important to understand attitudes and preferences about HIV prevention options, especially as new options become available. This study plans to evaluate preferences over time among cisgender women and trans individuals who are taking medication to prevent HIV, and among cisgender women and trans individuals who are not taking medication but are at risk of HIV. The investigators enroll up to 175 participants who visit the HIV prevention clinic, and the investigators will ask participants to complete questionnaires at regular follow up visits and between visits. This study may help the investigators understand how best to prevent HIV among people at risk.

Being studied: Individualized Feedback

Conditions: HIV Prevention; Pre-exposure Prophylaxis

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Cisgender women and trans individuals who have an indication for PrEP and have 1) decided to take PrEP, 2) decided not to take PrEP, or 3) decided to discontinue PrEP

Exclusion Criteria

  • Cannot provide informed consent
  • Living with HIV

Recruiting US locations

  • Columbia University Medical Center

    New York, NY 10032

    Site contact: Deborah Theodore, MD · 212-305-2201 · dat2132@cumc.columbia.edu

Study contacts (from the official record)

  • Deborah Theodore, MD · 2123052201 · dat2132@cumc.columbia.edu
Stick2PrEP Cisgender Women and Trans Individuals (NCT05165745) | Bored Studies